Literature DB >> 24924392

Simultaneous quantification of alternatively spliced transcripts in a single droplet digital PCR reaction.

Bing Sun1, Lian Tao1, Yun-Ling Zheng1.   

Abstract

Human telomerase reverse transcriptase (hTERT) is an essential component required for telomerase activity and telomere maintenance. Several alternatively spliced forms of hTERT mRNA have been reported in human primary and tumor cells. Currently, however, there is no sensitive and accurate method for the simultaneous quantification of multiple alternatively spliced RNA transcripts, such as in the case of hTERT. Here we show droplet digital PCR (ddPCR) provides sensitive, simultaneous digital quantification in a single reaction of two alternatively spliced single deletion hTERT transcripts (α-/β+ and α+/β-) as well as the opportunity to manually quantify non-deletion (α+/β+) and double deletion (α-/β-) transcripts. Our ddPCR method enables direct comparison among four alternatively spliced mRNAs without the need for internal standards or multiple primer pairs specific for each variant as real-time PCR (qPCR) requires, thus eliminating potential variation due to differences in PCR amplification efficiency.

Entities:  

Keywords:  RNA alternative splicing; ddPCR; droplet digital PCR; hTERT; qPCR; real-time PCR; telomerase; telomere

Mesh:

Substances:

Year:  2014        PMID: 24924392     DOI: 10.2144/000114179

Source DB:  PubMed          Journal:  Biotechniques        ISSN: 0736-6205            Impact factor:   1.993


  6 in total

1.  POT1 germline mutations but not TERT promoter mutations are implicated in melanoma susceptibility in a large cohort of Spanish melanoma families.

Authors:  M Potrony; J A Puig-Butille; M Ribera-Sola; V Iyer; C D Robles-Espinoza; P Aguilera; C Carrera; J Malvehy; C Badenas; M T Landi; D J Adams; S Puig
Journal:  Br J Dermatol       Date:  2019-02-27       Impact factor: 9.302

Review 2.  Pharmacology of Modulators of Alternative Splicing.

Authors:  David O Bates; Jonathan C Morris; Sebastian Oltean; Lucy F Donaldson
Journal:  Pharmacol Rev       Date:  2017-01       Impact factor: 25.468

3.  MicroRNA Signature of Lung Adenocarcinoma with EGFR Exon 19 Deletion.

Authors:  Lixia Ju; Mingquan Han; Xuefei Li; Chao Zhao
Journal:  J Cancer       Date:  2017-05-11       Impact factor: 4.207

4.  Single well, single-common primer pair, dual probe, duplex qPCR assay for the quantification of mRNA splicing variants.

Authors:  Janice Wang; Winifred P Wong; Emma O Link; Shantel Olivares; Cade T Adelman; Anne S Henkel; Malek El Muayed
Journal:  Biol Methods Protoc       Date:  2021-02-09

5.  Prognostic value of circulating tumour DNA in patients undergoing curative resection for pancreatic cancer.

Authors:  Naoto Hadano; Yoshiaki Murakami; Kenichiro Uemura; Yasusi Hashimoto; Naru Kondo; Naoya Nakagawa; Taijiro Sueda; Eiso Hiyama
Journal:  Br J Cancer       Date:  2016-06-09       Impact factor: 7.640

6.  Evaluation of relative quantification of alternatively spliced transcripts using droplet digital PCR.

Authors:  Mattias Van Heetvelde; Wouter Van Loocke; Wim Trypsteen; Annelot Baert; Katrien Vanderheyden; Brecht Crombez; Jo Vandesompele; Kim De Leeneer; Kathleen B M Claes
Journal:  Biomol Detect Quantif       Date:  2017-09-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.